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Background: Growing evidence shows that, in vivo, the precursor of Nerve Growth Factor (NGF), proNGF, displays
biological activities different from those of its mature NGF counterpart, mediated by distinct, and somewhat
complementary, receptor binding properties. NGF and proNGF induce distinct transcriptional signatures in target
cells, highlighting their different bioactivities. In vivo, proNGF and mature NGF coexist. It was proposed that the
relative proNGF/NGF ratio is important for their biological outcomes, especially in pathological conditions, since
proNGF, the principal form of NGF in Central Nervous System (CNS), is increased in Alzheimer’s disease brains.
These observations raise a relevant question: does proNGF, in the presence of NGF, influence the NGF
transcriptional response and viceversa? In order to understand the specific proNGF effect on NGF activity,
depending on the relative proNGF/NGF concentration, we investigated whether proNGF affects the pattern of
well-known NGF-regulated mRNAs.
Results: To test any influence of proNGF on pure NGF expression fingerprinting, the expression level of a set of
candidate genes was analysed by qReal-Time PCR in rat adrenal pheochromocytoma cell line PC12, treated with a
mixture of NGF and proNGF recombinant proteins, in different stoichiometric ratios. These candidates were selected
amongst a set of genes well-known as being rapidly induced by NGF treatment. We found that, when PC12 cells
are treated with proNGF/NGF mixtures, a unique pattern of gene expression, which does not overlap with that
deriving from treatment with either proNGF or NGF alone, is induced. The specific effect is also dependent on the
stoichiometric composition of the mixture. The proNGF/NGF equimolar mixture seems to partially neutralize the
specific effects of the proNGF or NGF individual treatments, showing a weaker overall response, compared to the
individual contributions of NGF and proNGF alone.
Conclusions: Using gene expression as a functional read-out, our data demonstrate that the relative availability of
NGF and proNGF in vivo might modulate the biological outcome of these ligands.
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NGF, the prototype member of the neurotrophin protein
family, is translated as a pre-pro-protein, processed by
furin protease in the trans-Golgi network or by extracel-
lular proteases, to give rise to mature NGF [1]. Besides
its suggested roles in the regulation of neurotrophin se-
cretion [2] and as an intramolecular chaperone for the
folding of mature NGF [3], the precursor proNGF was
found to display independent biological activities [4-6],
different from those of its mature NGF counterpart,
mediated by distinct, and somewhat complementary,
receptor binding properties. In particular, proNGF binding
with higher affinity to p75NTR [6] is increased by the pres-
ence of sortilin, a specific receptor for pro-neurotrophins
[7]. Our recent finding demonstrates that NGF and
proNGF activate distinct transcriptional signatures in target
cells, highlighting their different bioactivities [8]. However,
the relevant question whether the concomitant presence of
proNGF and NGF affects the NGF transcriptional response
has not been addressed yet. The interest in such analysis
derives from a number of observations, in both physio-
logical and pathological conditions.
First, proNGF and NGF coexist in vivo [9]. During
ageing, proNGF increases in rat cortex and hippocam-
pus, whereas NGF gradually decreases in the cortex.
Second, in pathological conditions, such as prodromal
and, more significantly, end-stage Alzheimer’s Disease,
the levels of proNGF in the brain increase [10-12].
These alterations are suggested to play a role in the
reduced brain plasticity and in the cognitive decline ob-
served during ageing and neurodegeneration [13-15]. The
balance between proNGF and NGF levels and signalling in
the brain is thus a key determinant for brain homeostasis,
with its disruption possibly leading to neurodegeneration
[16,17]. We have previously characterized the distinct prop-
erties of proNGF and NGF signalling by gene expression
microarray in PC12 cells and identified two subsets of dif-
ferentially expressed genes that could be ascribed to a “pure
proNGF” and a “pure NGF” signalling, respectively [8]. This
initial characterization of the transcriptional signature of
proNGF in PC12 cells confirmed that the mature and the
precursor NGF proteins are biologically different, showing
a different transcriptional signature. In order to understand
the proNGF specific modulatory effect on NGF induced
transcriptional activity and to test any influence of proNGF
on “pure NGF” expression fingerprinting, PC12 cells were
treated with a mixture of both recombinant proteins, in
different stoichiometric ratios. Thus, we analysed the
expression level of candidate genes, mainly selected
among well-known NGF-induced genes [8,18-20]. A
specific “proNGF effect” on NGF-induced gene expres-
sion was identified. Interestingly, a group of differentially
expressed genes (about 50% of the analysed genes) shows
two opposite trends 30 minutes after the single NGF orproNGF treatment. Moreover, when both neurotrophins
are added, the coexistence of proNGF and NGF induces a
“novel effect, peculiar to the mixture”, not induced by the
single ligand addition.
Results
Experimental design and analysis overview
The expression of sixty-five genes was analysed, by
qReal-Time PCR, in PC12 cells treated with only NGF,
only proNGF or a mixture with both for different times
(5, 15, 30 and 60 minutes), as schematized in Additional
file 1. The set of genes was selected because of their well
characterized response to NGF [18,8], or because they
are involved in proNGF processing (directly, in the case
of furin, or indirectly, in the case of tissue plasminogen acti-
vator) [2,21], or in modulating survival/apoptosis choices
and differentiation programs. The functional interconnec-
tion between the selected genes was evaluated by means
of the STRING database (http://string-db.org), a public
repository of experimentally known and computationally
predicted protein-protein interactions. The interaction
network (Figure 1) shows that the genes are very sparsely
connected and are thus independent, except for genes
encoding for some transcription factors, early activated
by NGF (Jun, Fos, Creb, Myc and few others [18,22-24]).
Data analysis was carried out on the expression levels,
after treatment with proNGF-only (proNGF/NGF 20/
0 ng/ml or 200/0 ng/ml), NGF-only (proNGF/NGF 0/
10 ng/ml) or proNGF/NGF mixtures (20/10 ng/ml, equi-
molar; 200/10 ng/ml; 40/10 ng/ml).
Early effects of proNGF and NGF on gene expression
We recently showed that proNGF and NGF activate
largely distinct transcriptional programs after 60 minutes
of incubation [8]: in this work we extend the investiga-
tion to shorter time intervals. We characterized the gene
expression profile of the chosen subset of genes in PC12
cells treated with proNGF (20 ng/ml) or NGF (10 ng/
ml) for 5, 15, 30 and 60 minutes. Genes were grouped
on the basis of their differential responses to proNGF or
NGF alone (Figure 2A). It is noteworthy that already at
5 minutes the modulation of a number of mRNAs can
be observed. This suggests a possible regulation at the
translational level.
We identified two groups of genes mainly responding
to proNGF (group I) or NGF only (group II), as reported
in Figure 2A, (average Log2 Fold change ratio). As for
the latter group, data show that proNGF is much slower
in the induction of some IEGs, such as Fosl1, Egr1, Egr2
[20,25] induced by NGF very early on (15 minutes).
ProNGF induces a modest increase of the expression of
these mRNAs only at 60 minutes (Figure 2A). At this
time point, our previous analysis [8] had shown that the
induction of these genes is much stronger in response to
Figure 1 Functional networks of analysed genes. Functional connections among the analysed genes, according to the String protein-protein
interaction database (http://string-db.org/), with High Confidence threshold parameter.
Arisi et al. BMC Neuroscience 2014, 15:48 Page 3 of 16
http://www.biomedcentral.com/1471-2202/15/48NGF than to proNGF. On the other hand, group I displays,
at 30 minutes, an up-regulated response to proNGF (20 ng/
ml) compared to that to NGF (10 ng/ml), which is weakly
down-regulated. Interestingly, the trend for this group of
genes is inverted after 1 hour of treatment, when the re-
sponse to proNGF is reduced, and NGF shows an up-
regulatory effect on the same genes, even larger than that
displayed by proNGF (Figure 2A). The histogram in
Figure 2B summarizes the responses to NGF or proNGF
and shows that, at 30 minutes, the group I genes display
a large up-regulation by proNGF, and a weak down-
regulation by NGF. The histogram also shows that higher
doses of proNGF (200 ng/ml) anticipate the up-regulated
response observed at 30 minutes for the group I genes,
differentially modulated by proNGF, displaying an earlier
activity response (15 minutes) compared to the lower
proNGF dose. As for the group II genes, the time point of
15 minutes highlights an overall opposite action of NGF,
compared to the higher dose of proNGF. Log2 Fold change
of the pure proNGF or NGF responses at the different time
points analysed is reported in Additional file 1 (the group I
is highlighted in light blue).The equimolar proNGF/NGF mixture induces changes in
PC12 cells that neither singly produces
Regarding the question whether and how the coexist-
ence of NGF and proNGF would influence the response
of either ligand, we demonstrate that the proNGF/NGF
equimolar mixture (20/10 ng/ml) shows coherent gene
expression profiles at 5, 15, 30 and 60 minutes, without
major differences at the different time-points analysed
(Figure 3). The proNGF/NGF equimolar mixture seems
to partially neutralize the specific effects of the proNGF
or NGF individual treatments, showing a weaker overall
response, compared to the individual contributions of
NGF and proNGF alone (Figure 3). Figure 4 shows the
average |Log2 Fold Change| and the average standard
deviation of samples treated with NGF (proNGF/NGF
0/10 ng/ml), proNGF (proNGF/NGF 20/0 ng/ml) and
the equimolar mixture (proNGF/NGF 20/10 ng/ml).
The equimolar mixture shows a weaker response in
Group I genes, as underlined also by a much smaller stand-
ard deviation, hence a reduced variability across time.
Hierarchical clustering of samples in response to different
proNGF/NGF treatments was computed (Figure 5). First,
Figure 2 (See legend on next page.)
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(See figure on previous page.)
Figure 2 Plots of Log2 Fold Change for analysed genes, following single neurotrophin treatments. (A) Plots of Log2 Fold Change (FC)
for the analysed genes, at 5, 15, 30, 60 minutes, with the two treatments: proNGF/NGF = 0/10 ng/ml and proNGF/NGF = 20/0 ng/ml. At 5 and
15 minutes, a third treatment with high proNGF is shown, proNGF/NGF = 200/0 ng/ml. The Group I genes show a stronger proNGF-mediated
effect at 15 minutes with proNGF/NGF =200/0 and at 30 minutes with proNGF/NGF =20/0. (B) Average Log2 Fold Change ratio in the two groups
of genes shown in (A). The proNGF/NGF =200/0 and proNGF/NGF =20/0 treatments originate a similar response, with a significant increase in
gene transcription at 15 and 30 minutes, respectively: this effect is even more significant for the genes of group I highlighted in Figure 2A. (*****)
1-tail T-test with unequal variance, p < 0.00001. (***) 1-tail T-test with unequal variance, p < 0.001. (*) 1-tail T-test with unequal variance, p < 0.05.
Error bars are s.e.m.
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compared to the NGF one. The branching diagram repre-
sents a hierarchical tree of categories (different treatments)
based on degree of similarity in the expression response.
Different treatments showing similar expression response
are closer in the tree; the distance is proportional to inter-
samples dissimilarity. The chosen metric (“non centered
Pearson” correlation) takes into account both the shape of
profiles and the expression levels, compared to the com-
monly used “centered Pearson” correlation. The diagram in
Figure 5 highlights the low degree of similarity between the
NGF and proNGF responses at 30 minutes, whereas the
NGF response is closest to the proNGF one at 60 minutes,
with a high degree of similarity. Moreover, treatments with
NGF, both pure and in mixtures, cluster together while
proNGF is farther in the tree, supporting the first con-
clusion of a different gene activation pattern by proNGF
compared to NGF.
Time courses of responses
To evaluate how the responses to proNGF alone or to
an equimolar mixture of NGF and proNGF differ from
the NGF response, the similarity between the responses
at different times were computed with a correlation
coefficient (“centered Pearson”). The time-course of the
gene expression profiles at 4 time points (5, 15, 30, 60 mi-
nutes) in 3 experimental conditions (10 ng/ml NGF, or
20 ng/ml proNGF or a mixture of both) was analysed and
compared, as shown in Figure 6. In the graphical represen-
tation, each subplot corresponds to the average expression
responses for a group of genes that shows a homogeneous
response pattern. In PC12 cells exposed to a mixture of
10 ng/ml NGF plus 20 ng/ml proNGF (1:1 stoichiometry),
response patterns are defined as “mixture-specific re-
sponses” peculiar to the mixture, and different from the
profile observed after the addition of NGF or proNGF
alone. A group of expression response patterns is identi-
fied, that mimics the trend observed after the single
addition of NGF, defined as “NGF-like”. proNGF-like re-
sponses are not observed, upon mixture treatment with
1:1 ratio (Figure 6). Several examples, indicated as “no
response” in Figure 6, are shown, after addition of the
proNGF/NGF equimolar mixture. Such observation sug-
gests a potential mutual antagonist role of proNGF andNGF in the equimolar range, such that each ligand can-
cels and counteracts the response to the other, confirming
the overall result described in Figure 4, where the equi-
molar mixture of NGF and proNGF induces a reduced
modulation for some of the analysed genes.
Effects of increasing the proNGF concentration in the
proNGF/NGF mixture
We analysed the behaviour of individual genes, in re-
sponse to treatments with NGF or proNGF alone (as a
reference for comparison to pure NGF or pure proNGF
responses) or with mixtures of NGF and proNGF, either
at equal stoichiometry or with increasing amount of
proNGF (20 ng/ml proNGF, 40 ng/ml proNGF, and
200 ng/ml proNGF plus 10 ng/ml NGF, corresponding
respectively to stoichiometric ratios of 1:1, 2:1, and
10:1). The interest in evaluating the expression re-
sponses to increasing doses of proNGF derives from
in vivo data, showing the coexistence of both proNGF
and NGF [21,26] and the increased proNGF levels in
pathological conditions [10,11]. Therefore, the modulatory
effect of proNGF on genes known to be NGF-responders is
an interesting and relevant issue, particularly at early time
points (5 minutes, see Figure 7 and 15 minutes, see
Figure 8), when limited proteolysis of proNGF has the
chance to occur. Expression patterns for induced genes
were clustered according to two parameters: i) response
to individual NGF or proNGF ligands (are they similar or
different?) and ii) response to the proNGF/NGF mixture
(is it similar to the response to either ligand alone?).
At the 5 minutes time point, the following categories
of expression patterns were identified (Figure 7):
A)Response to NGF or proNGF alone: similar.
Response to mixtures: mixture-specific, depending on
the proNGF/NGF ratio; two representative groups of
response profiles were identified (A, left and right).
B) In the first group (B left), the response to NGF is
higher than the response to proNGF alone, in the
second (B right) it reverses. The response to the
proNGF/NGF mixture is more similar to the
response to proNGF alone (proNGF-like). C)
Response to NGF or proNGF alone: different.
Response to NGF alone: lower (C, left) or greater (C,
Figure 3 Plots of Log2 Fold Change for analysed genes, following single neurotrophin and equimolar mixture treatments. Plots of Log2
Fold Change for the 65 selected genes, with the treatments with NGF (proNGF/NGF 0/10 ng/ml), proNGF (proNGF/NGF 20/0 ng/ml) and the
equimolar mixture of proNGF/NGF 20/10 ng/ml, each at 5,15,30 and 60 minutes.
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Figure 4 Histograms of Log2 Fold Change for analysed genes, following single neurotrophin and equimolar mixture treatments.
(Upper panel) Average |Log2 Fold Change| (absolute value across time points) in the two groups of genes, with the treatments with NGF
(proNGF/NGF 0/10 ng/ml), proNGF (proNGF/NGF 20/0 ng/ml) and the equimolar mixture of proNGF/NGF 20/10 ng/ml. (Lower panel) Average
standard deviation (across time points) of |Log2 Fold Change| in the two groups of genes, with the treatments with NGF (proNGF/NGF 0/10 ng/
ml), proNGF (proNGF/NGF 20/0 ng/ml) and the equimolar mixture of proNGF/NGF 20/10 ng/ml. The mixture shows a weaker response in Group I
genes, as underlined also by a much smaller variability across time. (****) 1-tail T-test with unequal variance, p < 0.0001. (*) 1-tail T-test with
unequal variance, p < 0.05. Error bars are s.e.m.
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to NGF (NGF-like); this appears to be the least
represented category. D) Response to NGF or
proNGF alone: different. Response to NGF alone:
lower (D, left) or greater (D, right) than to proNGF.
Response to mixtures: mixture specific, dependingon the proNGF/NGF ratio. A similar analysis was
performed at 15 minutes, and groups of expression
patterns were classified, according to the same
criteria (Figure 8): A) Response to NGF or proNGF
alone: similar. Response to mixtures: mixture-
specific, depending on the proNGF/NGF ratio; two
Figure 5 Hierarchical clustering of samples. Hierarchical clustering tree of samples, corresponding to the different experimental points
(treatments and times). The proNGF/NGF concentrations are expressed in ng/ml. The tree shows the gene expression similarity between
samples, by using the “non-centered Pearson” correlation, as a metric to compare the expression profiles. The y-axis indicates the distance
between samples. The colours of highlighted treatments correspond to those displayed in Figure 4. This diagram shows that the degree of
similarity between the NGF and proNGF responses at 30 minutes is low.
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showing a saturation effect with proNGF/NGF
increasing ratio. B) Response to NGF or proNGF
alone: different. Response to proNGF/NGF mixtures:
similar to proNGF. C) Response to NGF or proNGF
alone: different. Response to mixtures: similar to
NGF. D) Response to NGF or proNGF alone:
different. Response to mixtures: mixture-specific,
depending on the proNGF/NGF ratio. Compared to
the 5 minutes data sample (Figure 7), two response
patterns are not represented in the 15 minutes
dataset (Figures 8B and C).
At 5 minutes (Figure 7), the responses to NGF or
proNGF alone differ frequently; in those cases, the response
to mixtures is variable, either similar to proNGF or NGF-
responses, or peculiar to the proNGF/NGF mixture (mix-
ture-specific). At 15 minutes (Figure 8), when the responses
to NGF or proNGF alone differ, most frequently repre-
sented genes show a mixture-specific response, different
from the NGF- or proNGF-responses. Moreover, increasing
the amount of proNGF in the mixture (20 ng, 40 ng and
200 ng/ml) does not always produce a linear dose–response
outcome in the expression pattern of the genes under
consideration. Indeed, the response is often reverted, at the
highest proNGF concentration (see Figure 8, cluster A left
panel and cluster D).
To support the concept that NGF and proNGF mixture
behaves differently from either NGF or proNGF alone,
we analysed the morphological changes triggered by theaddition of 10 ng/ml NGF, 20 ng/ml proNGF or an equi-
molar mixture of both molecules (proNGF/NGF 20/10 ng/
ml). Differentiated PC12 were analysed on the basis of the
neurite mean length for each type of treatment. Under our
experimental conditions, neurite length assessment showed
that, after 5 days of treatment, the proNGF/NGF 20/10 ng/
ml group of genes exhibit a significant increase in the
neurite mean length accounting for a 41% and 52% change
(Figure 9), with respect to the 10 ng/ml NGF, or 20 ng/ml
proNGF. The increase in the mean neurite length indicates
a different response of the proNGF/NGF treated group
compared to the single treatments.
Discussion
The role of proNGF is controversial, and both neuro-
trophic and apoptotic activities have been reported for
recombinant proNGF. It has been shown that proNGF
can also be neurotrophic, regardless of mutations or tags,
and no matter how it is purified or in which system it is
expressed. However, although proNGF is neurotrophic for
primary sympathetic neurons and for PC12 cells, it is re-
ported to be apoptotic for unprimed PC12 cells [27]. Fur-
thermore, proNGF has been reported to promote apoptosis
via its interaction with p75NTR and sortilin receptor [7,28].
Both proNGF and mature NGF exhibited neurotrophic ac-
tivity on PC12 cells, while the pro-domain itself promotes
cell death [29]. NGF and proNGF co-exist in vivo [9]. One
might therefore expect that the proNGF/NGF mixture
modulates the downstream effect of either neurotrophin
form, in ways depending on their ratio, and distinct from
Figure 6 (See legend on next page.)
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Figure 6 Time course of gene expression profiles. The figure shows the summary plots of expression profiles of selected genes, in three
different experimental conditions, at 5, 15, 30 and 60 minutes after treatment. The expression level is the Log2 Fold Change ratio relative to the
untreated condition. Each subplot is composed by three lines: the average expression value for the genes written on the left (red), average – standard
deviation (dotted green), average + standard deviation (dotted blue). Every frame corresponds to a different cluster of genes and is composed by three
plots: the response to 10 ng/ml NGF (left), the response to 20 ng/ml proNGF (center), the response to a mixture of 10 ng/ml NGF + 20 ng/ml proNGF
(right). To evaluate the similarity between the responses to the three treatments the “centered Pearson” correlation coefficients (NGF, proNGF), (NGF,
mixture), (proNGF, mixture) have been computed for each gene expression profile. The colours of the small rectangles below each plot indicate the
similarity between the responses within each cluster, based on the correlation coefficients (where coefficients > 60% the profiles are considered similar):
orange =NGF-like profile, blue = proNGF-like profile, green =mixture-like profile, grey = almost no response. The notes on the right summarize the
response to the mixture of 10 ng/ml NGF + 20 ng/ml proNGF.
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and how the concomitant presence of proNGF affects cell
responses to NGF.
Our data refer to the PC12 cells system and to mRNAs
expression read-out as a response signature. This experi-
mental system was chosen, together with the gene expres-
sion read-out, as a well defined system, for investigating
the complex question of the functional consequences of
signalling by mixtures of NGF/proNGF, in comparison to
signalling by pure proNGF or pure NGF. We expect that
proNGF/NGF mixtures might modulate the downstream
responses, depending on their ratio, in ways distinct from
those affected by NGF or proNGF alone, also in different
systems than PC12 cells. It remains however to be
ascertained whether and how the distinct signalling
behaviours of the NGF/proNGF mixture, here demon-
strated, also apply to neuronal cells. Thus, we have
analysed by qReal-Time PCR the expression of a set of
genes, in PC12 cells treated for short times with
proNGF, NGF or with a mixture of the two proteins.
The emphasis on short times was to minimize the
chance of processing of proNGF by cellular proteases
in the culture medium, which is known to occur at
times longer than a few hours [8].
From our results, we conclude that there are a signifi-
cant number of cases where proNGF has a prevalent ef-
fect over NGF. This effect is time dependent, as well as
dependent on the relative concentration of the two pro-
teins. Distinct proNGF-specific effects on NGF-induced
gene expressions were identified. It should be pointed
out that we do not imply to put forward a functional in-
terpretation of the gene expression changes observed.
Rather, we take the gene expression patterns as a finger-
printing read-out of possible actions of proNGF/NGF
mixtures, as compared to those regulated by NGF or
proNGF alone. Most of the selected genes are essentially
functionally unrelated (Figure 1) and any correlated be-
haviour, observed in the PC12 cellular model, could be
attributed to the specific treatment.
Taking into account single additions, among the se-
lected panel of genes, about 50% of Group I shows an
opposite trend in the single NGF or proNGF treatments
at 30 minutes. Higher doses of proNGF anticipate at15 minutes the proNGF up-regulated response, observed
at 30 minutes for that group of genes. This suggests
there may be a proNGF-induced dose-dependent effect on
early signalling. Hierarchical clustering of samples high-
lights this low degree of similarity between the NGF and
proNGF responses at 30 minutes. When NGF and proNGF
were added simultaneously, the effect of the mixture on
gene expression was often different from the effect of the
single ligands added separately. Although some NGF-
like responses were observed for the mixture (indicating
proNGF being neutral), in many cases the mixture be-
haved differently. In particular, in the case of an equimo-
lar mixture of proNGF and NGF, synergic, additive or
mutually antagonizing effects were observed for differ-
ent mRNAs. We can therefore identify a non-linear
“proNGF effect” interfering with the NGF-induced gene
expression.
Increased proNGF levels are observed during human age-
ing and pathological conditions [11,12]. This prompted us
to analyse the effect of increasing proNGF concentration in
the proNGF/NGF mixture. Different patterns of expression
responses were obtained. At 5 minutes, the responses to
NGF or proNGF alone are often different; in those cases,
the response to mixtures shows a variable pattern, either
similar to proNGF-response or to NGF-response or pecu-
liar to the mixture, whereas at 15 minutes, the most repre-
sented group of genes shows a mixture-specific response.
Moreover, the response is not always linear with the in-
creasing amount of proNGF, being often reverted at the
highest concentration. We conclude that the proNGF/NGF
mixture shows a mixture-specific signature, that at these
early time points (5 and 15 minutes) is not necessarily only
transcriptional, but may involve translational regulation
[30]. This aspect warrants to be further investigated. Our
data support the hypothesis that the relative concentration
of NGF and proNGF might be of importance for the bio-
logical outcome of the two proteins, in physiological and/or
pathological conditions and suggests that the proNGF/NGF
balance is a sensitive point of regulation in the homeosta-
sis of the system. We have recently described a transgenic
mouse model expressing a form of proNGF resistant to
furin cleavage [17], showing that different expression
levels of NGF and proNGF produce neurodegeneration
Figure 7 (See legend on next page.)
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Figure 7 Expression profiles of different proNGF/NGF mixtures at 5 minutes. The figure shows the behaviour of genes in five different
experimental conditions, 5 minutes after the treatments. Each single line plot is composed by 5 experimental points, respectively: 20 ng/ml
proNGF, 10 ng/ml NGF, proNGF/NGF = 20/10 ng/ml, proNGF/NGF = 40/10 ng/ml, proNGF/NGF = 200/10 ng/ml. Expression profiles have been
clustered based on two criteria: i) the responses to single NGF and proNGF ligands are similar or different ii) the shape of the response to
mixtures and their similarity to the response to ligands alone. A) Response to NGF or proNGF alone: similar. Response to mixtures: variable
depending on the proNGF/NGF ratio; left: first cluster of response profiles, right: second cluster of response profiles. B) Response to NGF or
proNGF alone: different. Response to mixtures: closer to proNGF; left: response to NGF alone > proNGF, right: response to NGF alone < proNGF.
C) Response to NGF or proNGF alone: different. Response to mixtures: closer to NGF; left: response to NGF alone > proNGF, right: response to
NGF alone < proNGF. D) Response to NGF or proNGF alone: different. Response to mixtures: variable depending on the proNGF/NGF ratio; left:
response to NGF alone > proNGF, right: response to NGF alone < proNGF. The notes and the prototype behaviours on the right summarize the
prototypical responses to the single neurotrophins and to the mixtures. Colours of treatments (blue, orange, green) are the same as Figure 6.
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rived from different founders [17]. The relative NGF and
proNGF availability has been reported to regulate innerv-
ation density in postnatal Superior Cervical Ganglion
(SCG) neurons: sub-saturating concentrations of proNGF
and NGF act synergically to promote neurite growth,
whereas the additive effect is not observed at saturating
concentration. Conversely, lack of synergic effect was ob-
served in trigeminal neurons, highlighting that subsets of
NGF-responsive neurons have distinctive responses to
NGF and proNGF [31]. Our data show that the mixture
of proNGF and NGF acts differently, depending on the
proNGF/NGF ratio, highlighting that conflict, synergism
and/or cancellation occur when both NGF and proNGF
downstream pathways are similarly activated through dif-
ferent receptors. The biochemical site of this conflict or
synergism is currently unknown, and most likely involves
interactions at the level of the signalling pathways, start-
ing from the receptor(s) level and determining distinct
downstream functional consequences. In any case, the in-
teractions between the NGF and proNGF signalling path-
ways, when concomitantly activated, can be described as
if the proNGF/NGF mixture functionally behaves as a
“new ligand”, distinct from either NGF or proNGF alone.
Conclusions
The regulation of proNGF and NGF relative concentra-
tions might be a highly relevant parameter governing
the final fate of a target cell, between differentiation,
maintenance of a differentiated phenotype, survival or
death. Different proNGF/NGF mixtures exert a fine
tuning of distinct receptors binding and thus their dif-
ferential signalling. In this complex scenario, we have
discovered, under well defined experimental conditions,
that the proNGF/NGF ratio induces a specific response,
up-regulating or down-regulating some genes, differently
than the individual proNGF or NGF ligands alone. Thus,
we show that the proNGF/NGF mixture induces gene
expression changes in PC12 cells that neither singly pro-
duces. This opens the possibility that in vivo a similar
functional interaction between NGF and proNGF signal-
ling may be operative.The main conclusion is that proNGF is clearly modu-
lating NGF gene expression and novel effects, peculiar
to the mixture, are detected. The data support the
idea that the relative proNGF/NGF concentration might
specifically contribute to different biological activities,
both in physiological and pathological conditions. Fur-
ther studies will include blocking NGF receptors with
specific antibodies to dissect the pathways involved and
the receptor and signalling specificity, downstream of
the proNGF/NGF mixture.
Methods
PC12 cell culture and treatment
Rat pheochromocytoma PC12 cells [32] (PC12 SB
subclone) were maintained with RPMI 1640 Medium
(Invitrogen) and grown as monolayer cultures on Falcon
dishes, supplemented with 10% Horse Serum (Invitrogen)
and 5% Foetal Calf Serum (Invitrogen), in a humidified at-
mosphere at 37°C and 5% CO2. PC12 cells were plated at
a concentration of 106/dish (100 mm plates, BD Falcon)
and kept in culture for 12 hours or 5 days for imaging
procedures. Cells were divided in four groups: PC12
treated with 10 ng/ml NGF, 20 ng/ml proNGF, with differ-
ent proNGF/NGF mixtures or untreated PC12 cells (zero
concentration of either ligand) (control group), following
different times of incubation (5, 15, 30 and 60 minutes).
NGF/ProNGF concentrations ranged from 1, 2 and 10
fold proNGF (in stoichiometrical terms), according to [8].
Two biological replicates were used for each time point
and treatment. For imaging procedures cells received a
medium change every two days, and were treated every
day with the same molecules concentrations as described
above. An additional group, which did not receive treat-
ment (control group), was used for cell survival and neur-
ite length assessment.
Imaging and cellular analysis
For imaging procedures plated cells were monitored
every day and images documentation were taken on an
inverted microscope (TiE; Nikon, Japan) equipped with
phase contrast objectives, with a cooled CCD camera
(Clara; Andor) and Niss Elements imaging software
Figure 8 (See legend on next page.)
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(See figure on previous page.)
Figure 8 Expression profiles of different proNGF/NGF mixtures at 15 minutes. The figure shows the behaviour of genes in five different
experimental conditions, 15 minutes after the treatments. Each single line plot is composed by 5 experimental points, respectively: 20 ng/ml
proNGF, 10 ng/ml NGF, proNGF/NGF = 20/10 ng/ml, proNGF/NGF = 40/10 ng/ml, proNGF/NGF = 200/10 ng/ml. Expression profiles have been
grouped based on two criteria: i) the responses to single NGF and proNGF ligands are similar or different ii) the shape of the response to mixtures
and their similarity to the response to ligands alone. A) Response to NGF or proNGF alone: similar. Response to mixtures: variable depending on the
proNGF/NGF ratio; left: first cluster of response profiles; right: second cluster of response profiles, with a saturation effect with proNGF/NGF
increasing ratio. B) Response to NGF or proNGF alone: different. Response to mixtures: similar to proNGF. C) Response to NGF or proNGF alone:
different. Response to mixtures: similar to NGF. D) Response to NGF or proNGF alone: different. Response to mixtures: variable depending on the
proNGF/NGF ratio; left: response to NGF alone > proNGF; right: response to NGF alone < proNGF. The notes on the right summarize the prototypical
responses to the single neurotrophins and to the mixtures. Colours of treatments (blue, orange, green) are the same as Figure 6.
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using Imaris Suite 7.4® (Bitplane A.G., Zurich, Switzerland)
or Image J 1.4 (http://rsbweb.nih.gov/ij/) softwares.
For assessment of neurite length, five fields (640 × 480
micron) randomly distributed, and derived from three
replicates of each experimental group, were taken with a
20× objective after 5 days of incubation. Due to the high
propensity of differentiated cells to form bidimensional
and tridimensional contact clusters, a manual strategy
for neurite length was adopted. For assessment of neur-
ite length, images were opened with Imaris and neurite
were traced with the line structure measurement tool.
Only neurites, which were clearly identifiable, were con-
sidered for analysis. On the basis of pilot analyses onFigure 9 Differentiation PC12 assay after 10 ng/ml NGF, 20/10 ng/ml pro
Contrast) images show differentiated PC12 cells after 5 days of treatment. The g
Standard Deviation (SD) of three independent experiments and statistically sign
(*p < 0.05 versus proNGF/NGF group). Note the increase in neurite length in the
Scale bar 40 μm.untreated cells, we decided to consider only neurite
which protruded at least for 5 μm from the cell body.
For production of figures, bright field images of cells were
taken with an objective 10× under a confocal laser scanning
microscope (Leica SP5, Leica Microsystems, Wetzlar,
Germany) equipped with a transmitted light detector
for Differential Interference Contrast (DIC; Nomarski)
acquisitions. Images were adjusted for brightness and
contrast, inhomogeneities of the brightness across the
image were corrected with Adobe Photoshop high-pass
filter and contrast of cellular edges was enhanced with
ImageJ CLAHE (Contrast Limited Adaptive Histogram
Equalization; http://rsbweb.nih.gov/ij/plugins/clahe/index.
html) filter plugin (block size, 89; histogram bins, 256;NGF/NGF, 20 ng/ml proNGF treatments. DIC (Differential Interference
raph displays the mean neurite length for each group. Values are mean +
ificant differences were calculated by unpaired-two tailed t-Student’s test
proNGF/NGF group compared to the NGF or proNGF alone treatments.
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Adobe Photoshop 6 and Adobe Illustrator 10.
RNA extraction
RNA was isolated from PC12 cells treated with NGF,
proNGF or different neurotrophin composition, following
different incubation times, as described above. PC12 cell
cultures were scraped and lysed with Trizol (Invitrogen)
and DNAse treated by Qiagen columns. RNA quantity was
determined on a NanoDrop UV–VIS. Only samples with
an absorbance ratio of 1.8 < OD260/OD280 < 2.0 were proc-
essed further. Each sample was then quality checked for
integrity using the Agilent BioAnalyzer 2100 (Agilent
G2938C, RNA 6000 nano kit).
Real-time qRT-PCR
The expression data of a set of mRNA candidates was
evaluated by qRT-PCR, using the two-step Applied
Biosystem 7900HTMicro Fluidic Card protocol. To analyse
the variation in gene expression levels of various commonly
used endogenous controls, a TaqMan® LowDensity En-
dogenous Control Panel was used (Applied Biosystems,
Foster City, CA). Sixty-five genes and 3 housekeeping
genes were analysed (68 genes). For quantification of gene
expression changes, the Ct method was used, to calculate
relative fold changes normalized against the housekeeping
genes: ribosomal RNA 18S, TATA binding protein (Tbp)
and glyceraldehyde 3- phosphate dehydrogenase (Gapdh).
Data analysis
The Group I genes (Figures 2, 3 and 4) were selected using
specific criteria. In summary, we chose genes that clearly
show a different response between the proNGF-only and
NGF-only treatments, particularly at 30 minutes. First, for
each gene at time t, we calculated the difference between
the Log2 fold change with the proNGF-only and NGF-only
treatments. Calling these differences DeltaFC (gene_i, t)
where i = (1…65) and t = (5,15,30,60) minutes. Each one of
the eventually selected 36 genes satisfies all the following
rules at the same time:
a) MAX(DeltaFC(gene_i, 5), DeltaFC(gene_i, 15),
DeltaFC(gene_i, 30), DeltaFC(gene_i, 60) = DeltaFC
(gene_i, 30)
b) DeltaFC(gene_i, 30) > 0.5
c) DeltaFC(gene_i, 60) < 0.0 OR DeltaFC(gene_i, 60) <
DeltaFC(gene_i, 30)
d) |DeltaFC(gene_i, 5)| < |DeltaFC(gene_i, 30)|
e) |DeltaFC(gene_i, 15)| < |DeltaFC(gene_i, 30)|
Significant differences highlighted in Figures 2B and
4 were obtained by 1-tail T-test with unequal variance
between samples. Hierarchical clustering analysis in Figure 5
was obtained using R-Bioconductor. Temporal profiles inFigure 6 were obtained in Microsoft Excel by clustering
genes with a “centered Pearson” correlation coefficient >
0.6. Concentration profiles in Figures 7 and 8 were obtained
in Microsoft Excel and MultiExperiment Viewer ver. 4.6
[33] based on their shapes, in particular taking into account
the difference between response to single neurotrophins
and to the NGF/proNGF mixtures. The network in Figure 1
was built using StringDB (http://string-db.org), a protein-
protein interaction database.
Additional file
Additional file 1: Log2 Fold Change ratios for the analysed selected
genes. Table of Log2 Fold Change ratio for the analysed 65 selected
genes, at 5, 15, 30, 60 minutes, with the three treatments, where proNGF/
NGF = P/N in ng/ml: NGF-only with P/N = 0/10, proNGF-only with P/N =
20/0 or P/N = 200/0. The 36 genes with a stronger proNGF-mediated ef-
fect at 30 minutes are highlighted in light blue. Colour scale corresponds
to Fold Change values.
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